Financial Data and Key Metrics Changes - Core Reckitt achieved 3.1% like-for-like net revenue growth and 0.3% volume growth, with a closer estimate of 1% when excluding the SAP pull-forward impact from the previous year [3][9] - Group like-for-like net revenue growth was reported at 1.1%, driven by the strong performance of Core Reckitt [9] - Emerging Markets saw a significant growth of 10.7%, with volume growth of 6.8% and a price/mix impact of 3.9% [10][21] Business Line Data and Key Metrics Changes - Intimate Wellness and Germ Protection categories experienced double-digit growth, particularly in China and India [10][15] - Seasonal OTC brands in Self Care declined mid-single digits due to higher retailer inventory levels at the start of the period, while VMS portfolio saw strong double-digit growth [15][19] - Essential Home reported a decline of 7% in like-for-like net revenue, attributed to a tough comparative period and SAP implementation impacts [18][21] Market Data and Key Metrics Changes - North America experienced a volume decline of 1.8% and a like-for-like net sales decline of 0.9%, with a positive price/mix of 0.9% [13] - Europe saw a 1.7% like-for-like net revenue decline, with volume down 4.7% and a price/mix increase of 3% [12] - Emerging Markets continued to show strong performance, with expectations of mid- to high-single-digit growth in Q2 and the second half of the year [22] Company Strategy and Development Direction - The company is focused on transforming Reckitt into a more efficient, world-class consumer health and hygiene company, with a sharpened focus on Powerbrands [3][24] - The Fuel for Growth program is expected to drive adjusted operating profit ahead of net revenue growth, with a target of 3% to 4% revenue growth for Core Reckitt for the year [21][23] - The planned exit from Essential Home is progressing, with the management team focused on improving performance and completing the separation process [6][7] Management's Comments on Operating Environment and Future Outlook - Management remains confident in the ability to mitigate tariff impacts through strong gross margins and diversified supply chains [5] - Despite macroeconomic uncertainties, the company maintains its fiscal '25 guidance, expecting group like-for-like net revenue growth of 2% to 4% [21][22] - The management team is optimistic about the performance of Intimate Wellness and Germ Protection, expecting sustained strong volume growth [44][61] Other Important Information - The company has initiated a GBP 1 billion share buyback program, with GBP 815 million already repurchased [20] - The new organizational structure is functioning effectively, with a focus on operational excellence and growth [8] Q&A Session Summary Question: What drove the delta versus expectations in Europe and North America? - Management noted a steeper drop-off in seasonal demand and significant retailer destocking impacting North America, while Europe faced macro volatility affecting consumer behavior [29][30][32] Question: What gives confidence in offsetting Essential Home's negative performance in Q2? - Management highlighted the stability of the Essential Home business and expected sequential improvement in Q2, supported by promotional activities and calendar launches [34][35][61] Question: Are there any one-offs in the strong volume performance of Intimate Wellness and Germ Protection? - Management confirmed that the strong performance was due to genuine underlying demand and market share gains, with no significant one-offs [43][44] Question: What are the sell-out trends in North America and Europe? - Sell-out trends in Europe are mid-single-digit growth, while North America has seen a slowdown to low single digits, primarily due to destocking and seasonal resets [51][52][53] Question: How will the Essential Home sale impact cash returns and buyback plans? - Management clarified that there is no announced delay in the Essential Home sale process, but acknowledged that market conditions could affect the timeline [91] Question: Is destocking becoming apparent outside of OTC and VMS? - Management indicated that the most pronounced impact has been in OTC and VMS, with different retailers making varied decisions based on their market performance [95][96]
Reckitt Benckiser(RBGLY) - 2025 Q1 - Earnings Call Transcript